EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11523-023-00994-2.

Detalles Bibliográficos
Autores principales: Le, Xiuning, Nadler, Eric, Costa, Daniel B., Heymach, John Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663258/
https://www.ncbi.nlm.nih.gov/pubmed/37792237
http://dx.doi.org/10.1007/s11523-023-00994-2
_version_ 1785138359224500224
author Le, Xiuning
Nadler, Eric
Costa, Daniel B.
Heymach, John Victor
author_facet Le, Xiuning
Nadler, Eric
Costa, Daniel B.
Heymach, John Victor
author_sort Le, Xiuning
collection PubMed
description SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11523-023-00994-2.
format Online
Article
Text
id pubmed-10663258
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-106632582023-10-04 EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast Le, Xiuning Nadler, Eric Costa, Daniel B. Heymach, John Victor Target Oncol Commentary SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11523-023-00994-2. Springer International Publishing 2023-10-04 2023 /pmc/articles/PMC10663258/ /pubmed/37792237 http://dx.doi.org/10.1007/s11523-023-00994-2 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Commentary
Le, Xiuning
Nadler, Eric
Costa, Daniel B.
Heymach, John Victor
EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_full EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_fullStr EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_full_unstemmed EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_short EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
title_sort egfr tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer harboring uncommon egfr mutations: a podcast
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663258/
https://www.ncbi.nlm.nih.gov/pubmed/37792237
http://dx.doi.org/10.1007/s11523-023-00994-2
work_keys_str_mv AT lexiuning egfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast
AT nadlereric egfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast
AT costadanielb egfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast
AT heymachjohnvictor egfrtyrosinekinaseinhibitorsforthetreatmentofmetastaticnonsmallcelllungcancerharboringuncommonegfrmutationsapodcast

Ejemplares similares